In this MEDtalk, PhD student Jonas Rudbæk explains how systemic inflammatory changes are present in the preclinical development of IBD many years before diagnosis. The unidentified trigger may induce pathological changes, including dysregulated immune responses, dysbiosis, intestinal barrier dysfunction, and glycol changes.